<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="rapid-communication" dtd-version="2.3">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molbank</journal-id>
      <journal-title>Molbank</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molbank</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molbank</abbrev-journal-title>
      <issn pub-type="epub">1422-8599</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/M551</article-id>
      <article-id pub-id-type="publisher-id">molbank-2007-M551</article-id>
      <article-categories>
        <subj-group>
          <subject>Short Note</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Synthesis of Mono- and Dibromo-Derivatives of 1-Phenylpyrazol-3-ol</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Nedzelskyt&#x117;</surname>
            <given-names>Egl&#x117;</given-names>
          </name>
		  <xref rid="af1-molbank-2007-M551" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Martynaitis</surname>
            <given-names>Vytas</given-names>
          </name>
		  <xref rid="af1-molbank-2007-M551" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#x160;a&#x10D;kus</surname>
            <given-names>Algirdas</given-names>
          </name>
		  <xref rid="af1-molbank-2007-M551" ref-type="aff">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Eller</surname>
            <given-names>Gernot A.</given-names>
          </name>
		  <xref rid="af2-molbank-2007-M551" ref-type="aff">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Holzer</surname>
            <given-names>Wolfgang</given-names>
          </name>
		  <xref rid="af2-molbank-2007-M551" ref-type="aff">b</xref>
          <xref rid="c1-molbank-2007-M551" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-molbank-2007-M551">a Institute of Synthetic Chemistry, Kaunas University of Technology, Radvil&#x117;n&#x173; pl. 19, LT-50254 Kaunas, Lithuania</aff>
      <aff id="af2-molbank-2007-M551">b Department of Drug and Natural Product Synthesis, Faculty of Life Sciences, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria</aff>
      <author-notes>
        <corresp id="c1-molbank-2007-M551"><label>*</label>Author to whom correspondence should be addressed. Tel: +43-1-4277-55623; E-mail: <email>wolfgang.holzer@univie.ac.at</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>05</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>07</month>
        <year>2007</year>
      </pub-date>
      <volume>2007</volume>
      <issue>3</issue>
      <elocation-id>M551</elocation-id>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>01</month>
          <year>2007</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>02</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2007 by MDPI (http://www.mdpi.org/).</copyright-statement>
        <copyright-year>2007</copyright-year>
        <license>
          <p>Reproduction is permitted for noncommercial purposes.</p>
        </license>
      </permissions>
	  <abstract>
        <p>Dependent on the reaction conditions, 1-phenylpyrazol-3-ol and bromine give either 4-bromo-1-phenylpyrazol-3-ol (2a) or 4-bromo-1-(4-bromophenyl)pyrazol-3-ol (2b). Treatment of 2a or 2b with refluxing acetic anhydride leads to the corresponding <italic>O</italic>-acetyl derivatives 3a and 3b, respectively. Detailed spectroscopic data (<sup>1</sup>H NMR, <sup>13</sup>C NMR, <sup>15</sup>N NMR, MS, IR) for 2b, 3a and 3b are presented.</p>
      </abstract>
      <kwd-group>
        <kwd>1-phenylpyrazol-3-ol</kwd>
		<kwd>bromination</kwd>
		<kwd>O-acetylation</kwd>
		<kwd>NMR spectroscopy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
      <p>In the course of investigations regarding Pd-catalyzed cross coupling reactions with halopyrazoles [<xref ref-type="bibr" rid="B1-molbank-2007-M551">1</xref>], we prepared 4-bromo-1-phenylpyrazol-3-ol (2a) via reaction of 1-phenylpyrazol-3-ol (1) with one equivalent of bromine in high yield similarly to a previously described procedure [<xref ref-type="bibr" rid="B2-molbank-2007-M551">2</xref>]. In this respect it seemed interesting for us, if treatment of 1 with an excess of Br<sub>2</sub> would lead to a dibromination product (introduction of a bromo atom also into the phenyl ring) and thus to a synthon with two different targets for further C&#x2013;C bond formation. Such a behaviour was reported in a related case, namely in the bromination of 1-phenylpyrazole, where the use of excess bromine together with severe reaction conditions was found to give 15% 4-bromo-1-(4-bromphenyl)pyrazole besides the main product 4-bromo-1-phenylpyrazole (65%) [<xref ref-type="bibr" rid="B3-molbank-2007-M551">3</xref>].</p>
      <p>We found that treatment of 1 with 3 equivalents of bromine in a solution of boiling carbon tetrachloride gave the dibromination product 2b in 82% yield (<xref ref-type="scheme" rid="molbank-2007-M551-sch001">Scheme 1</xref>). The structure of 2b was unambiguously determined by spectroscopic methods (<sup>1</sup>H, <sup>13</sup>C, and <sup>15</sup>N NMR, MS) and CHN analysis. Furthermore, treatment of 2a and 2b with boiling acetic anhydride afforded the corresponding <italic>O</italic>-acetyl products 3a and 3b in high yield (<xref ref-type="scheme" rid="molbank-2007-M551-sch002">Scheme 2</xref>).</p>
    <sec>
      <title>4-Bromo-1-(4-bromophenyl)-1<italic>H</italic>-pyrazol-3-ol (2b)</title>
      <p>To a well stirred solution of hydroxypyrazole 1 [<xref ref-type="bibr" rid="B4-molbank-2007-M551">4</xref>] (1 g, 6.25 mmol) in carbon tetrachloride (30 mL) a solution of bromine (0.32 mL, 6.25 mmol) in carbon tetrachloride (8 mL) was added dropwise during 1 h, and stirring was continued for 2 h at room temperature. Then the reaction temperature was increased to reach reflux temperature within 1 h while adding a second equivalent of bromine (0.32 mL, 6.25 mmol) in carbon tetrachloride (8 mL). After the addition was complete, stirring was continued for further 5 h at reflux temperature. Then another equivalent of bromine (0.32 mL, 6.25 mmol) in carbon tetrachloride (8 mL) was added dropwise during 1 h, and stirring was continued for further 9 h at reflux temperature. The reaction mixture was then allowed to cool to room temperature; the precipitated solid was filtered off, washed with carbon tetrachloride (15 mL), and recrystallized from aqueous ethanol to afford 1.63 g (82%) of pure 2b.</p>
      <p>Melting point: 199&#x2013;201 &#xB0;C, yellowish crystals.</p>
      <p><sup>1</sup>H NMR (300 MHz, DMSO-<italic>d</italic><sub>6</sub>) [<xref ref-type="bibr" rid="B6-molbank-2007-M551">6</xref>]: &#x3B4; (ppm) 11.07 (s, 1H, OH), 8.54 (s, 1H, H-5), 7.62 (m, 4H, Ph H-2,3,5,6).</p>
      <p><sup>13</sup>C NMR (75 MHz, DMSO-<italic>d</italic><sub>6</sub>) [<xref ref-type="bibr" rid="B6-molbank-2007-M551">6</xref>]: &#x3B4; (ppm) 159.6 (C-3, <sup>3</sup><italic>J</italic>(C-3,H-5) = 8.8 Hz), 138.5 (Ph C-1), 132.2 (Ph C-3,5), 128.7 (C-5, <sup>1</sup><italic>J</italic> = 195.0 Hz), 118.6 (Ph C-2,6), 117.3 (Ph C-4), 82.7 (C-4, <sup>2</sup><italic>J</italic>(C-4,H-5) = 5.0 Hz).</p>
      <p><sup>15</sup>N NMR (50 MHz, DMSO-<italic>d</italic><sub>6</sub>) [<xref ref-type="bibr" rid="B7-molbank-2007-M551">7</xref>]: &#x3B4; (ppm) &#x2212;119.4 (N-2), &#x2212;189.4 (N-1).</p>
      <p>MS (m/z, %) [<xref ref-type="bibr" rid="B8-molbank-2007-M551">8</xref>]: 320 (M<sup>+</sup>, 49), 318 (M<sup>+</sup>, 100), 316 (M<sup>+</sup>, 45), 239 (22), 237 (21), 157 (23), 157 (23), 155 (19). </p>
      <p>Elemental Analysis: Calculated for C<sub>9</sub>H<sub>6</sub>Br<sub>2</sub>N<sub>2</sub>O (317.96): C, 34.00%; H, 1.90%; N, 8.81%. Found: C, 34.24%; H, 1.95%; N, 8.64%.</p>
    </sec>
    <sec>
      <title>4-Bromo-1-phenyl-1<italic>H</italic>-pyrazol-3-yl acetate (3a)</title>
      <p>Bromopyrazole 2a (1.91 g, 8 mmol) &#x2013; which had been prepared by treatment of hydroxypyrazole 1 with one equivalent of bromine at room temperature following a known procedure [<xref ref-type="bibr" rid="B2-molbank-2007-M551">2</xref>] &#x2013; and excess acetic anhydride (25 mL) were heated to reflux for 30 min. Then, H<sub>2</sub>O (15 mL) was added and the solution was stirred for further 30 min. The mixture was poured into ice-water (50 mL) and stirred for 30 min. Then the precipitate was filtered off, washed with H<sub>2</sub>O, and dried to give 2.07 g (92%) of pure 3a.</p>
      <p>Melting point: 82&#x2013;85 &#xB0;C, off-white crystals.</p>
      <p>IR (KBr) [<xref ref-type="bibr" rid="B5-molbank-2007-M551">5</xref>]: 1758 cm<sup>&#x2212;1</sup> (C=O).</p>
      <p><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) [<xref ref-type="bibr" rid="B6-molbank-2007-M551">6</xref>]: &#x3B4; (ppm) 7.90 (s, 1H, H-5), 7.57 (m, 2H, Ph H-2,6), 7.43 (m, 2H, Ph H-3,5), 7.29 (m, 1H, Ph H-4), 2.38 (s, 3H, CH<sub>3</sub>).</p>
      <p><sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) [<xref ref-type="bibr" rid="B6-molbank-2007-M551">6</xref>]: &#x3B4; (ppm) 167.6 (CO, <sup>2</sup><italic>J</italic>(CO,CH<sub>3</sub>) = 7.1 Hz), 154.0 (C-3, <sup>3</sup><italic>J</italic>(C-3,H-5) = 9.4 Hz), 139.2 (Ph C-1), 129.5 (Ph C-3,5), 128.4 (C-5, <sup>1</sup><italic>J</italic> = 194.3 Hz), 127.0 (Ph C-4), 118.5 (Ph C-2,6), 87.7 (C-4, <sup>2</sup><italic>J</italic>(C-4,H-5) = 5.1 Hz), 20.4 (CH<sub>3</sub>, <sup>1</sup><italic>J</italic> = 131.0 Hz).</p>
      <p><sup>15</sup>N NMR (50 MHz, CDCl<sub>3</sub>) [<xref ref-type="bibr" rid="B7-molbank-2007-M551">7</xref>]: &#x3B4; (ppm) &#x2212;177.0 (N-1); N-2 not found.</p>
      <p>MS (m/z, %) [<xref ref-type="bibr" rid="B8-molbank-2007-M551">8</xref>]: 282 (M<sup>+</sup>, 6), 280 (M<sup>+</sup>, 6), 240 (100), 238 (99), 104 (49), 77 (84), 51 (30), 43 (52).</p>
      <p>Elemental Analysis: Calculated for C<sub>11</sub>H<sub>9</sub>BrN<sub>2</sub>O<sub>2</sub> (281.11): C, 47.00%; H, 3.23%; N, 9.97%. Found: C, 46.74%; H, 3.07%; N, 9.84%.</p>
    </sec>
    <sec>
      <title>4-Bromo-1-(4-bromophenyl)-1<italic>H</italic>-pyrazol-3-yl acetate (3b)</title>
      <p>Dibromopyrazole 2b (1.27 g, 4 mmol) and excess acetic anhydride (15 mL) were refluxed for 30 min. Then H<sub>2</sub>O (10 mL) was added and the solution was stirred for further 30 min. The mixture was poured into ice-water (50 mL) and stirred for 30 min. Then the precipitate was filtered off, washed with H<sub>2</sub>O, and dried to give 1.17 g (81%) of pure 3b.</p>
      <p>Melting point: 77 &#xB0;C, beige powder.</p>
      <p>IR (KBr) [<xref ref-type="bibr" rid="B5-molbank-2007-M551">5</xref>]: 1780, 1761 cm<sup>&#x2212;1</sup> (C=O).</p>
      <p><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) [<xref ref-type="bibr" rid="B6-molbank-2007-M551">6</xref>]: &#x3B4; (ppm) 7.87 (s, 1H, H-5), 7.55 (m, 2H, Ph H-3,5), 7.46 (m, 2H, Ph H-2,6), 2.38 (s, 3H, CH<sub>3</sub>).</p>
      <p><sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) [<xref ref-type="bibr" rid="B6-molbank-2007-M551">6</xref>]: &#x3B4; (ppm) 167.5 (CO, <sup>2</sup><italic>J</italic>(CO,CH<sub>3</sub>) = 7.1 Hz), 154.4 (C-3, <sup>3</sup><italic>J</italic>(C-3,H-5) = 9.4 Hz), 138.3 (Ph C-1), 132.6 (Ph C-3,5), 128.3 (C-5, <sup>1</sup><italic>J</italic> = 194.3 Hz), 120.4 (Ph C-4), 120.0 (Ph C-2,6), 88.4 (C-4, <sup>2</sup><italic>J</italic>(C-4,H-5) = 5.0 Hz), 20.4 (CH<sub>3</sub>, <sup>1</sup><italic>J</italic> = 130.7 Hz).</p>
      <p><sup>15</sup>N NMR (50 MHz, CDCl<sub>3</sub>) [<xref ref-type="bibr" rid="B7-molbank-2007-M551">7</xref>]: &#x3B4; (ppm) &#x2212;99.2 (N-2), &#x2212;179.3 (N-1).</p>
      <p>MS (m/z, %) [<xref ref-type="bibr" rid="B8-molbank-2007-M551">8</xref>]: 362 (M<sup>+</sup>, 1), 360 (M<sup>+</sup>, 3), 358 (M<sup>+</sup>, 1), 320 (28), 318 (60), 316 (28), 157 (26), 155 (25), 76 (29), 75 (30), 43 (100). </p>
      <p>Elemental Analysis: Calculated for C<sub>11</sub>H<sub>8</sub>Br<sub>2</sub>N<sub>2</sub>O<sub>2</sub> (360.00): C, 36.70%; H, 2.24%; N, 7.78%. Found: C, 36.82%; H, 2.19%; N, 7.76%.</p>
    </sec>
  </body>
  <back>
  <app-group>
    <app id="app1-molbank-2007-M551">
        <title>Supplementary materials</title>
        <supplementary-material id="molbank-2007-M551-s001" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M551-s001-mod.mol">
   <label>Supplementary File 1</label>
</supplementary-material>
        <supplementary-material id="molbank-2007-M551-s002" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M551-s001.mol">
   <label>Supplementary File 2</label>
</supplementary-material>
<supplementary-material id="molbank-2007-M551-s003" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M551-s002-mod.mol">
   <label>Supplementary File 3</label>
</supplementary-material>
<supplementary-material id="molbank-2007-M551-s004" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M551-s002.mol">
   <label>Supplementary File 4</label>
</supplementary-material>
<supplementary-material id="molbank-2007-M551-s005" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M551-s003-mod.mol">
   <label>Supplementary File 5</label>
</supplementary-material>
        <supplementary-material id="molbank-2007-M551-s006" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M551-s003.mol">
   <label>Supplementary File 6</label>
</supplementary-material>
<supplementary-material id="molbank-2007-M551-s007" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M551-s004-mod.mol">
   <label>Supplementary File 7</label>
</supplementary-material>
<supplementary-material id="molbank-2007-M551-s008" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M551-s004.mol">
   <label>Supplementary File 8</label>
</supplementary-material>
    </app>
</app-group>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molbank-2007-M551">
        <label>1.</label>
        <citation citation-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Nedzelskyt&#x117;</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Martynaitis</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>&#x160;a&#x10D;kus</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Eller</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Holzer</surname>
              <given-names>W.</given-names>
            </name>
          </person-group>
          <comment>manuscript in preparation</comment>
        </citation>
      </ref>
      <ref id="B2-molbank-2007-M551">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>O'Brien</surname>
              <given-names>D.F.</given-names>
            </name>
            <name>
              <surname>Gates</surname>
              <given-names>J.W.</given-names>
              <suffix>Jr.</suffix>
            </name>
          </person-group>
          <source>J. Org. Chem.</source>
          <year>1966</year>
          <volume>31</volume>
          <fpage>1538</fpage>
          <lpage>1542</lpage>
        </citation>
      </ref>
      <ref id="B3-molbank-2007-M551">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Finar</surname>
              <given-names>I.L.</given-names>
            </name>
            <name>
              <surname>Foster</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <source>J. Chem. Soc. C</source>
          <year>1967</year>
          <fpage>1494</fpage>
          <lpage>1497</lpage>
        </citation>
      </ref>
      <ref id="B4-molbank-2007-M551">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harries</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Loth</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <source>Ber. Dtsch. Chem. Ges.</source>
          <year>1896</year>
          <volume>29</volume>
          <fpage>513</fpage>
          <lpage>520</lpage>
        </citation>
      </ref>
      <ref id="B5-molbank-2007-M551">
        <label>5.</label>
        <note>
          <p>Obtained on a Perkin-Elmer FTIR 1605 spectrophotometer or on a Perkin-Elmer FTIR Spectrum 1000 spectrometer.</p>
        </note>
      </ref>
      <ref id="B6-molbank-2007-M551">
        <label>6.</label>
        <note>
          <p>Obtained on a Varian UnityPlus 300 spectrometer (299.95 MHz for <sup>1</sup>H, 75.43 MHz for <sup>13</sup>C) at 28 &#xB0;C. The centre of the solvent signal was used as an internal standard which was related to TMS with &#x3B4; 2.49 ppm (<sup>1</sup>H NMR in DMSO-<italic>d</italic><sub>6</sub>), &#x3B4; 7.26 ppm (<sup>1</sup>H NMR in CDCl<sub>3</sub>), &#x3B4; 39.5 ppm (<sup>13</sup>C NMR in DMSO-<italic>d</italic><sub>6</sub>), and &#x3B4; 77.0 ppm (<sup>13</sup>C NMR in CDCl<sub>3</sub>).</p>
        </note>
      </ref>
      <ref id="B7-molbank-2007-M551">
        <label>7.</label>
        <note>
          <p>Obtained on a Bruker Avance 500 spectrometer (50.68 MHz for <sup>15</sup>N) and referenced against neat, external nitromethane (coaxial capillary).</p>
        </note>
      </ref>
      <ref id="B8-molbank-2007-M551">
        <label>8.</label>
        <note>
          <p>Obtained on a Shimadzu QP 1000 instrument (EI, 70eV).</p>
          </note>
      </ref>
    </ref-list>
    <sec sec-type="display-objects">
      <title>Schemes</title>
      <fig id="molbank-2007-M551-sch001" position="float">
        <object-id pub-id-type="pii">molbank-2007-M551-sch001_Scheme 1</object-id>
        <label>Scheme 1</label>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M551-sch001.tif"/>
      </fig>
      <fig id="molbank-2007-M551-sch002" position="float">
        <object-id pub-id-type="pii">molbank-2007-M551-sch002_Scheme 2</object-id>
        <label>Scheme 2</label>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molbank-2007-M551-sch002.tif"/>
      </fig>
    </sec>
  </back>
</article>
